Pathological Consequences of Host Response to Parasite

American Trypanosomiasis

Volumn , Issue , 2010, Pages 669-690

  Hontebeyrie, Mireille ^a   Truyens, Carine ^b   Brenière, Simone Frédérique ^c  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882432385     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384876-5.00025-3     Document Type: Chapter

References (164)

1. Abel L.C., Kalil J., Cunha-Neto E. Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13 driven human T cell clone that recognizes cardiac myosin. Braz. J. Med. Biol. Res. 1997, 36:1305-1308.
2. Abel L.C., Rizzo L.V., Ianni B., Albuquerque F., Bacal F., Carrara D., et al. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J. Autoimmun. 2001, 17:99-107.
3. Abrahamson I.A., Coffman R.L. Trypanosoma cruzi: IL10, TNF, IFN-γ and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 1996, 84:231-244.
4. Acosta A.M., Santos-Buch C.A. Autoimmune myocarditis induces by Trypanosoma cruzi. Circulation 1985, 71:1255-1261.
5. Alvarez M.G., Postan M., Weatherly D.B., Albareda M.C., Sidney J., Sette A., et al. HLA class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease. PloS Negl. Trop. Dis. 2008, 2. e288 doi:10.1371/journal.pntd.0000288.
6. Andrade L.O., Andrews N.W. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat. Rev. Microbiol. 2005, 3:819-823.
7. Anez N., Carrasco H., Parada H., Crisante G., Rojas A., Fuenmayor C., et al. Myocardial parasite persistence in chronic chagasic patients. Am. J. Trop. Med. Hyg. 1999, 60:726-732.
8. Antunez M.I., Feinstein R.E., Cardoni R.L., Gronvik K.O. Trypanosoma cruzi: T cell subpopulations in the Peyer's patches of BALB/c infected mice. Exp. Parasitol. 1997, 87:58-64.
9. Araujo-Jorge T.C., Waghabi M.C., Soeiro M.N., Keramidas M., Bailly S., Feige J.J. Pivotal role for TGF-beta in infectious heart disease: the case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy. Cytokine Growth Factor Rev. 2008, 19:405-413.
10. Aznar C., Lopez-Bergami P., Brandariz S., Mariette C., Liegeard P., de Deus Alves M.d.C., et al. Prevalence of anti-R13 antibodies in human Trypanosoma cruzi infection. FEMS Immunol. Med. Microbiol. 1995, 12:231-238.
11. Bahia-Oliveira L.M., Gomes J.A., Cançado J.R., Ferrari T.C., Lernos E.M., Luz Z.M., et al. Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during acute phase of Trypanosoma cruzi infection 14-30 years ago. J. Infect. Dis. 2000, 182:634-638.
12. Bandeira A., Larsson E.L., Forni L., Pereira P., Coutinho A. In vivo activated splenic T cells are refractory to interleukin 2 growth in vitro. Eur. J. Immunol. 1987, 17:901-908.
13. Barreira, A.A., Saïd, G., Krettli, A.U., Eisen, H., Joskowicz, M., 1982. Trypanosoma cruzi determine a multifocal inflammatory and demyelinative neuropathy in CBA mice. IX Reuniao Anual de Pesquisa Basica em Doença de Chagas, Caxambu, Brasil, 107.
14. Behbehani K., Pan S.C., Unanue E.R. Marked increase in Ia-bearing macrophages during Trypanosoma cruzi infection. Clin. Immunol. Immunopathol. 1981, 19:190-195.
15. Belloti C., Bocchi E.A., Villela-de-Moraes A., Higuchi M.L., Barbero-Marcial M., Sosa E., et al. In vivo detection of parasite antigens in hearts of patients with chronic Chagas' heart disease. Am. Heart J. 1996, 131:301-307.
16. Ben Younes Chennoufi A., Hontebeyrie-Joskowicz M., Tricottet V., Eisen H., Reynes M., Saïd G. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice. Trans. Roy. Soc. Trop. Med. Hyg. 1988, 82:77-83.
17. Ben Younes Chennoufi A., Saïd G., Eisen H., Durand A, Hontebeyrie-Joskowicz M. Cellular immunity to Trypanosoma cruzi is mediated by helper T cells (CD4+). Trans. R. Soc. Trop. Med. Hyg. 1988, 82:84-89.
18. Blanco A., Montamat E.E. Genetic variation among Trypanosoma cruzi populations. J. Exp. Zool. 1998, 282:62-70.
19. Bosseno M.F., Yacsik N., Vargas F., Brenière S.F. Selection of Trypanosoma cruzi clonal genotypes (clonet 20 and 39) isolated from Bolivian triatomines following subculture in liquid medium. Mem. Inst. Oswaldo Cruz 2000, 95:601-607.
20. Brandariz S., Schijman A., Vigliano C., Arteman P., Viotti R., Beldjord C., et al. Detection of parasite DNA in Chagas' heart disease. Lancet 1995, 346:1370-1371.
21. Brener Z. Biology of Trypanosoma cruzi. Annu. Rev. Microbiol. 1973, 27:347-382.
22. Brener Z. Immunity to Trypanosoma cruzi. Adv. Parasitol. 1980, 18:247-292.
23. Brenière S.F., Tibayrenc M., Antezana G., Pabon J., Carrasco R., Selaes H., et al. Preliminary results suggesting a tenuous or nonexistent relation between clinical forms of Chagas disease and isoenzyme strains of Trypanosoma cruzi. C. R. Acad. Sci. III. 1985, 300:555-557.
24. Brenière S.F., Carrasco R., Revollo S., Aparicio G., Desjeux P., Tibayrenc M. Chagas' disease in Bolivia: clinical and epidemiological features and zymodeme variability of Trypanosoma cruzi strains isolated from patients. Am. J. Trop. Med. Hyg. 1989, 41:521-529.
25. Brenière S.F., Bosseno M.F., Noireau F., Yacsik N., Liegeard P., Aznar C., et al. Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease. Mem. Inst. Oswaldo Cruz 2002, 97:289-295.
26. Bryan M.A., Norris K.A. Genetic immunization converts the Trypanosoma cruzi B-cell mitogen proline racemase to an effective mitogen. Infect. Immun. 2010, 78:810-822.
27. Burleigh B.A., Andrews N.W. The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Annu. Rev. Microbiol. 1995, 49:175-200.
28. Cabeza Meckert P., Hontebeyrie-Joskowicz M., Levin M.J., Laguens R.P. Trypanosoma cruzi: aberrant expression of class II major histocompatibility complex molecules in skeletal muscle fibers of chronically infected mice. Exp. Parasitol. 1991, 72:8-14.
29. Carlier, Y., Pinto Dias, J.C., Ostermayer Luquetti, A., Hontebeyrie, M., Torrico, F., Truyens, C., 2002. Trypanosomiase américaine ou maladie de Chagas. In: Encycl Med Chir, Maladies Infectieuses. Editions scientifiques et médicales Elsevier SAS (Ed.), Paris, tous droits réservés, 8-505-A-20, 21 p.
30. Chagas C. Nova entidade morbida do homen. Rezumo geral de estudos etiolojicos e clinicos. Mem. Inst. Oswaldo Cruz 1911, 3:219-275.
31. Chagas C. Trypanozomiase americana. Forma aguda da molestia (American Trypanosomiasis. The acute form-reprinted). Mem. Inst. Oswaldo Cruz 1916, 8:37-65.
32. Cordeiro da Silva A., Guevara Espinoza A., Taibi A., Ouaissi A., Minoprio P. A 24 kDa Trypanosoma cruzi antigen is a B cell activator. Immunology 1998, 94:189-196.
33. Correia-Neves M., Waltzinger C., Mathis D., Benoist C. The shaping of the T cell repertoire. Immunity 2001, 14:21-32.
34. Cossio P.M., Laguens R.P., Diez C., Szarfman A., Segal A., Arana R.M. Chagasic cardiopathy. Antibodies reacting with the plasma membrane of striated muscle and endothelial cells. Circulation 1974, 50:1252-1259.
35. Costa R.P., Gollob K.J., Fonseca L.L., Rocha M.O., Chaves A.C., Medrano-Mercado N., et al. T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells. Scand. J. Immunol. 2000, 51:511-519.
36. Coutinho A., Kazatchine M., Avrameas S. Natural autoantibodies. Curr. Opin. Immunol. 1995, 7:812-818.
37. Cunha-Neto E., Kalil J. Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity 2001, 34:187-192.
38. Cunha-Neto E., Duranti M., Gruber A., Zingales B., de Messias I., Stolf N., et al. Autoimmunity in Chagas disease cardiomyopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:3541-3545.
39. Cunha-Neto E., Coelho V., Guilherme L., Fiorelli A., Stolf N., Kalil J. Autoimmunity in Chagas disease: identification of cardiac myosine-B13 Trypanosoma cruzi protein cross-reactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J. Clin. Invest 1996, 98:1709-1712.
40. De Meis J., Mendes-da-Cruz D.A., Farias-de-Oliveira D.A., Correa-de-Santana E., Pinto-Mariz F., Cotta-de-Almeida V., et al. Atrophy of mesenteric lymph nodes in experimental Chagas' disease: differential role of Fas/Fas-L and TNFR1/TNF pathways. Microbes Infect 2006, 8:221-231.
41. De Meis J., Morrot A., Farias-de-Oliveira D.A., Serra Villa-Verde D.M., Savino W. Differential regional immune response in Chagas disease. PLoS Negl. Trop. Dis. 2009, 3:e417.
42. Dias J.C.P., Dias E., Filho O.M., Vitelli-Avelar D., Correia D., Lages E., et al. Further evidence of spontaneous cure in human Chagas disease. Rev. Soc. Brasil Med. Trop. 2008, 41:505-506.
43. D'Imperio Lima M.R., Joskowicz M., Coutinho A., Kipnis T., Eisen H. Very large isotypically atypical polyclonal plaque-forming cell responses in mice infected with Trypanosoma cruzi. Eur. J. Immunol. 1985, 15:201-203.
44. D'Imperio Lima M.R., Eisen H., Minoprio P., Joskowicz M., Coutinho A. Persistence of polyclonal B-cell activation with undetectable parasitemia in late stages of experimental Chagas' disease. J. Immunol. 1986, 137:353-356.
45. Dos Santos D.M., Talvani A., Guedes P.M., Machado-Coelho G.L., de Lana M., Bahia M.T. Trypanosoma cruzi: genetic diversity influences the profile of immunoglobulins during experimental infection. Exp. Parasitol. 2009, 121:8-14.
46. Dutra W.O., Martins-Filho O.A., Cançado J.R., Pinto-Dias J.C., Brener Z., Freeman Júnior G.L., et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int. Immunol. 1994, 6:499-506.
47. + B cells or activated T cells of chagasic patients, respectively. Scand. J. Immunol. 2000, 51:91-97.
48. Dutra W.O., Rocha M.O., Teixeira M.M. The clinical immunology of human Chagas disease. Trends Parasitol. 2005, 21:581-587.
49. Eisen H., Kahn S. Mimicry in Trypanosoma cruzi: fantasy and reality. Curr. Opin. Immunol. 1991, 3:507-510.
50. El Bouhdidi A., Truyens C., Rivera M.T., Bazin H., Carlier Y. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunol. 1994, 16:69-76.
51. Engman D.M., Leon J.S. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop. 2002, 81:123-132.
52. Fernandez-Mestre M.T., Jaraquemada D., Bruno R.E., Caro J., Layrisse Z. Analysis of the T-cell receptor beta-chain variable region (Vbeta) repertoire in chronic human Chagas' disease. Tissue Antigens 2002, 60:10-15.
53. Ferrari I., Levin M.J., Wallukat G., Elies R., Lebesque D., Chiale P., et al. Molecular mimicry between the immunodominant ribosomal P0 protein of Trypanosoma cruzi and a functional epitope on the human β-adrenergic receptor. J. Exp. Med. 1995, 182:59-65.
54. Fiuza J.A., Fujiwara R.T., Gomes J.A., Rocha M.O., Chaves A.T., de Araujo F.F., et al. Profile of central and effector memory T cells in the progression of chronic human Chagas disease. PloS Negl. Trop. Dis. 2009, 3:e512.
55. Gao W., Wortis H.H., Pereira M.A. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int. Immunol. 2002, 14:299-308.
56. Garg N., Tarleton R.L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 2002, 70:5547-5555.
57. Gironès N., Rodriguez C.I., Carrasco-Marin E., Hernaez R.F., Lopez de Rego J., Fresno M. Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. J. Clin. Invest. 2001, 107:985-993.
58. Gironès N., Cuervo H., Fresno M. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr. Top. Microbiol. Immunol. 2005, 296:89-123.
59. Gironès N., Carrasco-Marin E., Cuervo H., Guerrero N.A., Sanoja C., Sparrow J., et al. Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology. Ann. N. Y. Acad. Sci. 2007, 1107:434-444.
60. Gomes J.A.S., Bahia-Oliveira L.M.G., Rocha M.O.C., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 2003, 71:1185-1193.
61. Gomes J.A.S., Bahia-Oliveira L.M.G., Rocha M.O.C., Busek S.C., Teixeira M.M., Silva J.S., et al. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect. Immun. 2005, 73:7960-7966.
62. Grauert M.R., Houdayer M., Hontebeyrie-Joskowciz M. Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease. Clin. Exp. Immunol. 1993, 93:85-92.
63. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:3466-3469.
64. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. T lymphocyte function during experimental Chagas' disease: production of and response to interleukin 2. Eur. J. Immunol. 1985, 15:438-442.
65. Hernandez-Munain C., De Diego J.L., Alcina A., Fresno M. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies. J. Exp. Med. 1992, 175:1473-1482.
66. Hontebeyrie-Joskowicz M. Murine Trypanosoma cruzi infection: a role for Th2 cells in the immunopathology of chronic infection. Res. Immunol. 1991, 142:141-143.
67. Hontebeyrie-Joskowicz M., Saïd G., Milon G., Marchal G., Eisen H. L3T4+ T cells able to mediate parasite-specific delayed hypersensitivity play a role in the pathology of experimental Chagas' disease. Eur. J. Immunol. 1987, 17:1027-1033.
68. Iwai I.K., Juliano M.A., Juliano I., Kalil J., Cunha-Neto E. T-cell molecular mimicry in Chagas disease: identification and partial structure analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J. Autoimmun. 2005, 24:111-117.
69. Janeway C.A., Ron J., Katz M.E. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J. Immunol. 1987, 138:1051-1055.
70. Jones E.M., Colley D.G., Tostes S., Lopes E.R., Vnençak-Jones C.L., McCurley T.L. Amplification of Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am. Trop. Med. Hyg. 1993, 48:348-357.
71. Kalil J., Cunha-Neto E. Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last?. Parasitol. Today 1996, 12:396-399.
72. Kaplan D., Ferrari I., Lopez-Bergami P., Malher E., Levitus G., Chiale P., et al. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas' disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in Lupus. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10301-10306.
73. Kerner N., Liegeard P., Levin M.J., Hontebeyrie-Joskowicz M. Trypanosoma cruzi: antibodies to MAP-like protein in chronic Chagas' disease cross-react with mammalian cytoskeleton. Exp. Parasitol. 1991, 73:451-459.
74. Kierszenbaum F. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 1989, 12:210-223.
75. Köberlé F. Patogenia da molestia de Chagas. Rev. Goaiana Med. 1957, 3:155-180.
76. Köberlé F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 1968, 6:63-116.
77. Krettli A.U., Brener Z. Protective effects of specific antibodies in Trypanosoma cruzi infections. J. Immunol. 1976, 116:755-760.
78. Krieger J.L., Grammer S.F., Grey H.M., Chesnut R.W. Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses. J. Immunol. 1985, 135:2937-2945.
79. Laucella S.A., Postan M., Martin D., Fralish B.H., Albareda M.C., Alvarez M.G., et al. Frequency of interferon-?-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J. Infect. Dis. 2004, 18:909-918.
80. Leguizamon M.S., Mocetti E., Garcia Rivello H., Argibay P., Campetella O. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J. Infect. Dis. 1999, 180:1398-1402.
81. Leite de Moraes M.C., Coutinho A., Hontebeyrie-Joskowicz M., Minoprio P., Eisen H., Bandeira A. Skewed V beta TCR repertoire of CD8+ T cells in murine Trypanosoma cruzi infection. Int. Immunol. 1994, 6:387-392.
82. Leite de Moraes M.C., Hontebeyrie-Joskowicz M., Leboulanger F., Savino W., Dardenne M., Lepault F. Studies on the thymus in Chagas' disease. II. Thymocyte subset fluctuations in Trypanosoma cruzi infected mice: relationship to stress. Scand. J. Immunol. 1991, 33:267-275.
83. Leite de Moraes M.C., Hontebeyrie-Joskowicz M., Dardenne M., Savino W. Modulation of thymocyte subsets during acute and chronic phases of experimental Trypanosoma cruzi infection. Immunology 1992, 77:95-110.
84. Leite de Moraes M.C., Minoprio P., Dy M., Dardenne M., Savino W., et al. Endogenous IL-10 and IFN-? production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi. Scand. J. Immunol. 1994, 39:51-58.
85. Levin M.J. Molecular mimicry and Chagas' heart disease: high anti-R13 autoantibody levels are markers of severe Chagas heart complaint. Res. Immunol. 1991, 142:157-159.
86. Levin M.J., Mesri E., Benarous R., Levitus G., Schijman A., Levy-Yeyati P., et al. Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease. Am. J. Trop. Med. Hyg. 1989, 41:530-538.
87. Levin M.J., Levitus G., Kerner N., Lafon S., Schijman A., Levy-Yeyati P., et al. Autoantibodies in Chagas' heart disease: possible markers of severe Chagas' heart complaint. Mem. Inst. Oswaldo Cruz 1990, 85:539-543.
88. Levitus G., Hontebeyrie-Joskowicz M., Van Regenmortel M.H.V., Levin M.J. Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. Clin. Exp. Immunol. 1991, 85:413-417.
89. Luquetti A.O., Miles M.A., Rassi A., de Rezende J.M., de Souza A.A., Póvoa M.M., et al. Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central Brazil. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:462-470.
90. Macedo A.M., Pena S.D.J. Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease. Parasitol. Today 1998, 14:119-124.
91. Malher E., Sepulveda P., Jeannequin O., Liegeard P., Gounon P., Wallukat G., et al. A monoclonal antibody against the immunodominant epitope of the ribosomal P2? protein of Trypanosoma cruzi interacts with the human ?1-adrenergic receptor. Eur. J. Immunol. 2001, 31:2210-2216.
92. Mantuano-Barradas M., Henriques-Pons A., Araujo-Jorge T.C., Di Virgilio F., Coutinho-Silva R., Persechini P.M. Extracellular ATP induces cell death in CD4+ CD8+ double-positive thymocytes in mice infected with Trypanosoma cruzi. Microbes Infect 2003, 5:1363-1371.
93. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., Simoes M.V. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123.
94. Medeiros M.B., Guerra J.A., Lacerda M.V. Meningoencephalitis in a patient with acute Chagas disease in the Brazilian Amazon. Rev. Soc. Brasil. Med. Trop. 2008, 41:520-521.
95. Melo R.C., Brener Z. Tissue tropism of different Trypanosoma cruzi strains. J. Parasitol. 1978, 64:475-482.
96. Mendes-da-Cruz D.A., Silva J.S., Cotta-de-Almeida V., Savino W. Altered thymocyte migration during experimental acute Trypanosoma cruzi infection: combined role of fibronectin and the chemokines CXCL12 and CCL4. Eur. J. Immunol. 2006, 36:1486-1493.
97. Mesri E.A., Levitus G., Hontebeyrie-Joskowicz M., Van Regenmortel M.H.V., Levin M.J. Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematous ribosomal P protein epitope. J. Clin. Microbiol. 1990, 28:1219-1224.
98. Miles M.A., Cedillos R.A., Póvoa M.M., de Souza A.A., Prata A., Macedo V. Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian forms of Chagas' disease?. Lancet 1981, 20:1338-1340.
99. Minoprio P. Parasite polyclonal activators: new targets for vaccination approaches?. Intern. J. Parasitol. 2001, 31:588-591.
100. Minoprio P., Eisen H., Forni L., d'Imperio-Lima M.R., Joskowicz M., Coutinho A. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T and B cell responses. Scand. J. Immunol. 1986, 24:661-668.
101. Minoprio P., Coutinho A., Joskowicz M., d'Imperio-Lima M.R., Eisen H. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. II. Cytotoxic T lymphocytes. Scand. J. Immunol. 1986, 24:669-679.
102. Minoprio P., Eisen H., Joskowicz M., Pereira P., Coutinho A. Suppression of polyclonal antibody production in Trypanosoma cruzi infected mice by treatment with anti-L3T4 antibodies. J. Immunol. 1987, 139:545-550.
103. Minoprio P., Burlen O., Pereira P., Guilbert B., Andrade L., Hontebeyrie-Joskowicz M., et al. Most B cells in acute Trypanosoma cruzi infection lack parasite specificity. Scand. J. Immunol. 1988, 28:553-561.
104. Minoprio P., Itohara S., Heusser C., Tonegawa S., Coutinho A. Immunobiology of murine Trypanosoma cruzi infection: the predominance of parasite-non specific responses and the activation of TcR 1 T cells. Immunol. Rev. 1989, 112:183-188.
105. - T cells in the polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. Int. Immunol. 1989, 1:176-184.
106. Minoprio P., Coutinho A., Spinella S., Hontebeyrie-Joskowicz M. Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas disease. Int. Immunol. 1991, 3:427-433.
107. Minoprio P., Cury El Cheikh M.C., Murphy E., Hontebeyrie-Joskowicz M., Coffman R., Coutinho A., et al. Xid-associated resistance to experimental Chagas' disease is IFN-? dependent. J. Immunol. 1993, 151:4200-4208.
108. Montamat E.E., De Luca D'Oro G.M., Gallerano R.H., Sosa R., Blanco A. Characterization of Trypanosoma cruzi populations by zymodemes: correlation with clinical picture. Am. J. Trop. Med. Hyg. 1996, 55:625-628.
109. Montes C., Zuniga E., Minoprio P., Vottero-de-Cima E., Gruppi A. A Trypanosoma cruzi alkaline antigen induces polyclonal B cell activation of normal murine spleen cells by T-cell independent, BCR-directed stimulation. Scand. J. Immunol. 1999, 50:159-166.
110. Muñoz S., Lorca M., Muñoz P., Solari A. Highly homogeneous Trypanosoma cruzi populations in a low endemic region for Chagas disease: importance in the pathogenesis of Chagas disease in Chile. Rev. Med. Chil. 1994, 122:1231-1238.
111. Noel W., Raes G., Hassanzadeh G.G., De Baetselier P., Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004, 20:126-133.
112. Olivieri B.P., Farias-de-Oliveira D.A., Araujo-Jorge T.C., Cotta-de-Almeida V. Benznidazole therapy in Trypanosoma cruzi-infected mice blocks thymic involution and apoptosis of CD4+CD8+ double positive thymocytes. Antimicrob. Agents Chemother. 2005, 49:1981-1987.
113. Ortiz-Ortiz L., Parks D.E., Rodriguez M., Weigle W.O. Polyclonal B lymphocyte activation during Trypanosoma cruzi infection. J. Immunol. 1980, 124:121-126.
114. + T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol. 2009, 21:385-390.
115. Palmieri J.R., LaChance M.A., Conner D.H. Parasitic infection of the peripheral nervous system. Peripheral Neuropathy 1984, 2:1988-2009. Saunders, Philadelphia.
116. Peluffo G., Piacenza L., Irigoin F., Alvarez M.N., Radi R. L-arginine metabolism during interaction of Trypanosoma cruzi with host cells. Trends Parasitol. 2004, 20:363-369.
117. Pérez A.R., Roggero E., Nicora A., Palazzi J., Besedovsky H.O., del Rey A., et al. Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav. Immun. 2007, 21:890-900.
118. Pittella J.E.H. Central nervous system involvement in Chagas disease: a hundred-year-old history. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:973-978.
119. Rassi A., Borges C., Rezende J.M., Carneiro O., Salum J., Ribeiro J.B., et al. Fase aguda da doença de Chagas: aspectos clinicos observados em 18 casos. Rev. Goiana Med. 1958, 4:161-190.
120. Rassi J.A., Rassi A., Marin-Neto J.A. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem. Inst. Oswaldo Cruz 2009, 104:152-158.
121. Reina-San-Martin B., Degrave W., Rougeot C., Cosson A., Chamond N., Cordeiro-da-Silva A., et al. A B-cell mitogen from a pathogenic trypanosoma is a eukaryotic proline racemase. Nat. Med. 2000, 6:890-897.
122. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Gazzinelli G., Colley D.R., et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions. Am. J. Trop. Med. Hyg. 1993, 48:637-644.
123. Ribeiro dos Santos R., Rossi M.A., Laus J.L., Santana Silva J., Savino W., Mengel J. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J. Exp. Med. 1992, 175:29-39.
124. + T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplantation in the absence of Trypanosoma cruzi. Parasite Immunol. 2001, 23:93-101.
125. Rodrigues V., Agrelli G.S., Leon S.C., Silva Teixeira D.N., Tostes S., Rocha-Rodrigues D.B. Fas/Fas-L expression, apoptosis and low proliferative response are associated with heart failure in patients with chronic Chagas' disease. Microbes Infect. 2008, 10:29-37.
126. Romaña C. Acerca de un sintoma inicial de valor para el diagnostico de forma aguda de la enfermedad de Chagas. La conjuntivis esquizotripanozica unilateral (Hipitesis sobre puerta de entrada conjuntivale de la enfermedad). Publ. METRA 1935, 22:16-28.
127. + T cell subsets and non-T cells in the resistance of mice against Trypanosoma cruzi infection. Intern. J. Parasitol. 1990, 20:397-400.
128. Russo M., Starobinas N., Minoprio P., Coutinho A., Hontebeyrie-Joskowicz M. Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi infected mice after inactivation of helper T cells. Ann. Inst. Pasteur/Immunol. 1988, 139:225-236.
129. + T lymphocytes during acute Trypanosoma cruzi infection abolishes macrophage and B cell activation but not tissue inflammatory reaction. Mem. Inst. Oswaldo Cruz 1988, 83:527-538.
130. Russo M., Starobinas N., Ribeiro dos Santos R., Minoprio P., Eisen H., Hontebeyrie-Joskowicz M. Susceptible mice present higher macrophage activation than resistant mice during infection with myotropic strains of Trypanosoma cruzi. Parasite Immunol. 1989, 11:385-395.
131. Russo M., Starobinas N., Garibaldi Marcondes M.C., Minoprio P., Hontebeyrie-Joskowicz M. The influence of T cell subsets on Trypanosoma cruzi multiplication in different organs. Immunol. Lett. 1996, 49:163-168.
132. Saïd G., Joskowicz M., Barreira A.A., Eisen H. Neuropathy associated with experimental Chagas' disease. Ann. Neurol. 1985, 18:676-683.
133. Santos-Lima E.C., Minoprio P. Chagas disease is attenuated in mice lacking ?T cells. Infect. Immun. 1996, 64:215-221.
134. Savino W., Leite de Moraes M.C., Hontebeyrie-Joskowicz M., Dardenne M. Studies on the thymus in Chagas' disease. I. Changes in the thymic environment in mice acutely infected with Trypanosoma cruzi. Eur. J. Immunol. 1989, 19:1727-1733.
135. Schmuñis G.A. Autoimmunity in Chagas' disease. Mem. Inst. Oswaldo Cruz 1987, 82:287-310.
136. Sepulveda P., Liegeard P., Wallukat G., Levin M.J., Hontebeyrie M. Modulation of cardiocyte functional activity by antibodies against Trypanosoma cruzi ribosomal P2 protein C terminus. Infect. Immun. 2000, 68:5114-5119.
137. Silva-Monteiro E., Reis Lorenzato L., Kenji Nihei O., Junqueira M., Rabinovich G.A. Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection. Am. J. Pathol. 2007, 170:546-556.
138. Spinella S., Liegeard P., Guilbert B., Hontebeyrie-Joskowicz M. Anti-Ia treatment modulates specific and polyclonal antibody responses in Trypanosoma cruzi-infected mice. J. Autoimmun. 1989, 2:791-802.
139. Spinella S., Milon G., Hontebeyrie-Joskowicz M. A CD4 Th2 cell line isolated from mice chronically infected with T. cruzi induces IgG2 polyclonal response in vivo. Eur. J. Immunol. 1990, 20:1045-1051.
140. Spinella S., Liegeard P., Hontebeyrie-Joskowicz M. Trypanosoma cruzi: predominance of IgG2a in nonspecific humoral response during experimental Chagas' disease. Exp. Parasitol. 1992, 74:46-56.
141. Starobinas N., Russo M., Minoprio P., Hontebeyrie-Joskowicz M. Is TNF involved in early susceptibility of Trypanosoma cruzi infected C3H/He mice?. Res. Immunol. 1991, 142:117-122.
142. Sterin-Borda L., Perez Leiros C., Wald M., Cremaschi G., Borda E. Antibodies to beta1 et beta2 adrenoreceptors in Chagas' disease. Clin. Exp. Immunol. 1988, 74:349-354.
143. Sunnemak D., Andersson R., Harris R.A., Jeddi-Tehrani M., Orn A. Enhanced prevalence of T cells expressing TCRBV8S2 and TCRBV8S3 in hearts of chronically Trypanosoma cruzi-infected mice. Immunol. Lett. 1988, 60:171-177.
144. Tan H., Andrews N.W. Don't bother to knock-the cell invasion strategy of Trypanosoma cruzi. Trends Parasitol. 2002, 18(10):427-428.
145. Tarleton R. Chagas disease: a role for autoimmunity?. Trends Parasitol. 2003, 19:447-451.
146. Tarleton R., Sun J., Zhang L., Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect. Immun. 1994, 62:1820-1829.
147. Tarleton R.L., Reithinger R., Urbina J.A., Kitron U., Gürtler R.E. The challenges of Chagas disease-Grim outlook or glimmer of hope?. PLoS Med. 2007, 4:e332.
148. Teixeira A.R.L., Nascimento R.J., Sturm N.R. Evolution and pathology in Chagas disease. A review. Mem. Inst. Oswaldo Cruz 2006, 101:463-491.
149. Tekiel V., Oliveira G.C., Correa-Oliveira R., Sanchez D., Gonzalez-Cappa S.M. Chagas' disease: TCRBV9 over-representation and sequence oligoclonality in the fine specificity of T lymphocytes in target tissue of damage. Acta Trop. 2005, 94:15-24.
150. Torres C.M. Estudo do miocardio na molestia de Chagas (forma aguda). Mem. Inst. Oswaldo Cruz 1917, 9:114-139.
151. Torrico F., Heremans H., Rivera M.T., Van Marck E., Billiau A., Carlier Y. Endogenous IFN-? is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 1991, 146:3626-3632.
152. Truyens C., Torrico F., Angelo-Barrios A., Lucas R., Heremans H., de Baetselier P., Carlier Y. The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF alpha but not by anti-IL6 or anti-IFN-gamma antibodies. Parasite Immunol. 1995, 17:561-567.
153. Urbina J.A., Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 2003, 19:495-501.
154. Vago R.A., Macedo A.M., Adad S.J., Reis D.D., Correa-Oliveira R. PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic Chagas disease. Lancet 1996, 348:891-892.
155. Van Voorhis W.C. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J. Immunol. 1992, 148:239-248.
156. Van Voorhis W.C., Eisen H. FL-160: a surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J. Exp. Med. 1989, 169:641-648.
157. Venegas J., Coñoepan W., Pichuantes S., Miranda S., Apt W., Arribada A., et al. Differential distribution of Trypanosoma cruzi clones in human chronic chagasic cardiopathic and non-cardiopathic individuals. Acta Trop. 2009, 109:187-193.
158. Vianna G. Contribuçao para o estudo da anatomia patologica da molestia de Carlos Chagas. Mem. Inst. Oswaldo Cruz 1911, 3:276-293.
159. Viotti R., Vigliano C., Armenti H., Segura E.L. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am. Heart J. 1994, 127:151-162.
160. Virreira M., Truyens C., Alonso-Vega C., Brutus L., Jijena J., Torrico F., et al. Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns. Am. J. Trop. Med. Hyg. 2007, 77:102-106.
161. High regulatory T lymphocytes. Scand. J. Immunol. 2005, 62:297-308.
162. Vitelli-Avelar D.M., Sathler-Avelar R., Teixiera-Carvalho A., Pinto Dias J.C., Gontijo E.D., Faria A.M., et al. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease. Scand. J. Immunol. 2008, 68:516-525.
163. Vogt J., Alba Soto C.D., Mincz M.P., Mirkin G.A. Impaired Trypanosoma cruzi-specific IFN-γ secretion by T cells bearing the BV9 T-cell receptor is associated with local IL-10 production in non-lymphoid tissues of chronically infected mice. Microbes Infect 2008, 10:781-790.
164. Zingales B., Andrade S.G., Briones M.R., Campbell D.A., Chiari E., Fernandes O., et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz 2009, 104:1051-1054.